BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28186688)

  • 1. Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective.
    Yolcu ES; Shirwan H; Askenasy N
    Stem Cells Transl Med; 2017 Mar; 6(3):700-712. PubMed ID: 28186688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions.
    Yang YG
    Springer Semin Immunopathol; 2004 Nov; 26(1-2):187-200. PubMed ID: 15378269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed hematopoietic chimerism and transplantation tolerance.
    Nikolic B; Sykes M
    Immunol Res; 1997; 16(3):217-28. PubMed ID: 9379073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens.
    Shirasugi N; Adams AB; Durham MM; Lukacher AE; Xu H; Rees P; Cowan SR; Williams MA; Pearson TC; Larsen CP
    J Immunol; 2002 Sep; 169(5):2677-84. PubMed ID: 12193741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance.
    Chen JC; Kuo ML; Ou LS; Chang PY; Muench MO; Shen CR; Chang HL; Yu HY; Fu RH
    Cell Transplant; 2010; 19(12):1609-22. PubMed ID: 20719075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transplant tolerance through mixed chimerism].
    Zuber J
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S127-S130. PubMed ID: 28577733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance.
    Andreani M; Testi M; Lucarelli G
    Tissue Antigens; 2014 Mar; 83(3):137-46. PubMed ID: 24571472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megadose stem cell administration as a route to mixed chimerism.
    Or-Geva N; Reisner Y
    Curr Opin Organ Transplant; 2014 Aug; 19(4):334-41. PubMed ID: 24905022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
    Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
    J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants.
    Strober S
    Blood; 2016 Mar; 127(12):1539-43. PubMed ID: 26796362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
    Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
    J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver.
    Wang XQ; Lo CM; Chen L; Cheung CK; Yang ZF; Chen YX; Ng MN; Yu WC; Ming X; Zhang W; Ho DW; Chan SC; Fan ST
    Hepatology; 2012 Oct; 56(4):1557-66. PubMed ID: 22544823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed hematopoietic chimerism induces long-term tolerance to cardiac allografts in miniature swine.
    Schwarze ML; Menard MT; Fuchimoto Y; Huang CA; Houser S; Mawulawde K; Allison KS; Sachs DH; Madsen JC
    Ann Thorac Surg; 2000 Jul; 70(1):131-8; discussion 138-9. PubMed ID: 10921697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy.
    Takeuchi A; Kato K; Akashi K; Eto M
    Int J Urol; 2018 Feb; 25(2):112-120. PubMed ID: 29105189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenobiotics, chimerism and the induction of tolerance following organ transplantation.
    Delaney CP; Thomson AW; Demetris AJ; Starzl TE
    Ther Immunol; 1994 Jun; 1(3):153-64. PubMed ID: 7584491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.